HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by Yamaguchi, T Articles by Sugino, H Search for Related Content PubMed PubMed Citation Articles by Yamaguchi, T Articles by Sugino, H

Division of Molecular Cytology, Institute for Enzyme Research, University of Tokushima, 3-18-15, Kuramoto, Tokushima, 770-8503, Japan
¹ Harima Institute at Spring-8, RIKEN, Mikazuki, Sayo, Hyogo, 679-5148, Japan
² Division of Pharmacy, Tokushima University Hospital, 2-50-1, Kuramoto, Tokushima, 770-8503, Japan

(Requests for offprints should be addressed to A Kurisaki; Email: akikuri{at}hotmail.com)

(T Yamaguchi is now at Division of Pharmacy, Ehime University Hospital, Shitsukawa, Toon, 791-0295, Ehime, Japan)

The cytoplasmic immunophilin FKBP12, a 12 kDa FK506-binding protein, has been shown to act as an inhibitor for transforming growth factor-ß (TGF-ß) signaling. FKBP12 binds to the glycine- and serine-rich motif (GS motif) of the TGF-ß type I receptor, and functions as a secure switch to prevent the leaky signal. Upon stimulation with ligand, FKBP12 is released from the receptor to fully propagate the signal. We found that activin, a member of TGF-ß superfamily, also induced the dissociation of FKBP12 from the activin type I receptor (ALK4). However, we observed that the released FKBP12 associates again with the receptor a few hours later. FKBP12 also interacted with another inhibitory molecule of activin signal, Smad7, in an activin-dependent manner, and formed a complex with Smad7 on the type I receptor. FK506, a chemical ligand for FKBP12, which dissociates FKBP12 from the receptor, decreased the interaction between Smad7 and Smad ubiquitin regulatory factor 1 (Smurf1). FK506 also inhibited the ubiquitination of the type I receptor by Smurf1. These findings indicate a new inhibitory function of FKBP12 as an adaptor molecule for the Smad7–Smurf1 complex to regulate the duration of the activin signal.

This article has been cited by other articles:

				E. Glasgow and L. Mishra Transforming growth factor-{beta} signaling and ubiquitinators in cancer Endocr. Relat. Cancer, March 1, 2008; 15(1): 59 - 72. [Abstract] [Full Text] [PDF]

				F. S. KAPLAN, J. GROPPE, R. J. PIGNOLO, and E. M. SHORE Morphogen Receptor Genes and Metamorphogenes: Skeleton Keys to Metamorphosis Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 113 - 133. [Abstract] [Full Text] [PDF]